Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has results × Advanced Breast Cancer × Clear all

Phase

Phase 2 6 Phase 1 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 241 Carcinoma, Non-Small-Cell Lung 169 Prostatic Neoplasms 126 Neoplasms 125 Multiple Myeloma 99 Neoplasm Metastasis 73 Colorectal Neoplasms 69 Leukemia, Myeloid, Acute 63 Parkinson Disease 4, Autosomal Dominant Lewy Body 56 Lung Neoplasms 56 Melanoma 55 Lymphoma, Follicular 53 Lymphoma, Non-Hodgkin 52 Leukemia, Lymphocytic, Chronic, B-Cell 52 Papillomavirus Infections 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Leukemia 45 Lymphoma 43 Carcinoma, Renal Cell 42 Ovarian Neoplasms 41 Uterine Cervical Neoplasms 40 Keratosis, Actinic 39 Carcinoma, Hepatocellular 39 Recurrence 36 Pain 36 Urinary Bladder Neoplasms 29 Pancreatic Neoplasms 29 Head and Neck Neoplasms 29 Fallopian Tube Neoplasms 29 Stomach Neoplasms 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02054338 2019-08-28

VICTORIA

Pierre Fabre Medicament

Phase 3 Terminated

1,004 enrolled 11 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡